ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	29/182	191/7206	2.64302094605e-15
ko04650	Natural killer cell mediated cytotoxicity	19/182	97/7206	2.17233101557e-12
ko04380	Osteoclast differentiation	21/182	134/7206	1.31217741881e-11
ko05145	Toxoplasmosis	19/182	126/7206	2.61889681967e-10
ko04659	Th17 cell differentiation	17/182	106/7206	9.01758274358e-10
ko05340	Primary immunodeficiency	10/182	30/7206	1.60049060015e-09
ko05140	Leishmaniasis	14/182	75/7206	3.80483694806e-09
ko04064	NF-kappa B signaling pathway	15/182	96/7206	1.33553661136e-08
ko04062	Chemokine signaling pathway	21/182	201/7206	2.67624429063e-08
ko04658	Th1 and Th2 cell differentiation	14/182	96/7206	1.0215292428e-07
ko05321	Inflammatory bowel disease (IBD)	11/182	56/7206	1.09242151199e-07
ko05152	Tuberculosis	19/182	187/7206	2.01031505206e-07
ko04660	T cell receptor signaling pathway	15/182	124/7206	4.38903502742e-07
ko04630	Jak-STAT signaling pathway	15/182	132/7206	9.93246863027e-07
ko04621	NOD-like receptor signaling pathway	16/182	157/7206	1.86769657497e-06
ko04217	Necroptosis	17/182	178/7206	2.17972279391e-06
ko04612	Antigen processing and presentation	11/182	77/7206	3.09009028137e-06
ko04664	Fc epsilon RI signaling pathway	11/182	77/7206	3.09009028137e-06
ko05164	Influenza A	16/182	167/7206	4.22365941623e-06
ko05162	Measles	13/182	120/7206	9.17004112443e-06
ko04662	B cell receptor signaling pathway	11/182	88/7206	1.16266249669e-05
ko05330	Allograft rejection	6/182	24/7206	2.20285373547e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	16/182	191/7206	2.34487123812e-05
ko04620	Toll-like receptor signaling pathway	11/182	100/7206	3.95440851045e-05
ko04666	Fc gamma R-mediated phagocytosis	12/182	122/7206	5.40132590274e-05
ko04611	Platelet activation	14/182	163/7206	5.87293297689e-05
ko04670	Leukocyte transendothelial migration	13/182	151/7206	0.000105910411512
ko05144	Malaria	7/182	45/7206	0.000117714008306
ko04145	Phagosome	13/182	162/7206	0.000215217832861
ko04672	Intestinal immune network for IgA production	6/182	37/7206	0.000289600167527
ko05168	Herpes simplex infection	13/182	182/7206	0.000665666041816
ko05169	Epstein-Barr virus infection	14/182	206/7206	0.000682297633618
ko05320	Autoimmune thyroid disease	5/182	29/7206	0.000705695112209
ko05310	Asthma	4/182	17/7206	0.000724091898905
ko05132	Salmonella infection	9/182	98/7206	0.000780747982464
ko05146	Amoebiasis	9/182	99/7206	0.000840474913074
ko05332	Graft-versus-host disease	4/182	18/7206	0.000912747287165
ko04640	Hematopoietic cell lineage	7/182	64/7206	0.00107642689983
ko05323	Rheumatoid arthritis	8/182	89/7206	0.00175150142951
ko03050	Proteasome	6/182	54/7206	0.00225638290152
ko05416	Viral myocarditis	6/182	55/7206	0.00248056564
ko00051	Fructose and mannose metabolism	5/182	42/7206	0.00387908333141
ko05133	Pertussis	7/182	87/7206	0.00623362637374
ko04933	AGE-RAGE signaling pathway in diabetic complications	9/182	135/7206	0.00699544034276
ko04940	Type I diabetes mellitus	4/182	32/7206	0.00814621889148
ko04750	Inflammatory mediator regulation of TRP channels	8/182	122/7206	0.0118358532146
ko05142	Chagas disease (American trypanosomiasis)	8/182	130/7206	0.0168586883936
ko04514	Cell adhesion molecules (CAMs)	8/182	130/7206	0.0168586883936
ko04072	Phospholipase D signaling pathway	11/182	197/7206	0.0170522872928
ko05166	HTLV-I infection	14/182	292/7206	0.019957661498
ko05034	Alcoholism	1/182	238/7206	0.0322439073446
ko04066	HIF-1 signaling pathway	7/182	123/7206	0.0357663102904
ko00590	Arachidonic acid metabolism	4/182	52/7206	0.0416378312289
ko05161	Hepatitis B	9/182	173/7206	0.0421585420872
ko01524	Platinum drug resistance	5/182	76/7206	0.0425819488957